(A) Free-swimming cells (bottom left) were confined (bottom right) at a fixed height using confinement slides with micro-spacers (Liu et al., 2015; Le Berre et al., 2014) (top). (B) Confined S. …
(A) Most (but not all) S. rosetta cells retracted their flagellum within 500 s of confinement at 2 μm. (B–D) The flagellum regenerated after release from confinement in approximately the same …
(A) Schematic drawing of a rosette colony of S. rosetta (from Brunet and King, 2017). (B–E) Cells within rosettes became amoeboid under 2 μm confinement. (A) An unconfined rosette. (C and D) Time …
The strain used was SrEpac and the starting cell type was slow swimmer.
Cells were attached to the substrate by poly-d-lysine to minimize cell movement and help visualizing both conversion of flagellates into amoeboid cells, and reversion of amoeboid cells back into …
(A) Protrusions in eukaryotic crawling cells can either be F-actin-filled pseudopods that form by polymerization of F-actin (pink) reticulated by the Arp2/3 complex (purple, left) or F-actin-free …
Cellular phenotypes observed after pharmacological inhibitor treatments (as shown) under 1 μm confinement. White arrowheads indicate blebs.
A flow-through chamber design was used to maintain confinement during immunostaining of amoeboid cells (see Materials and methods).
Time lapse imaging of a LifeAct-mCherry-expressing live cell (Video 5) by DIC (left column) and fluorescence microscopy (middle column) revealed membrane dynamics and actin localization during bleb …
(A) Top: MRLC-mTFP fluorescence in four unconfined flagellate S. rosetta cells from a chain colony (Dayel et al., 2011). The position of the microvilli (black arrowheads) can be inferred from weak …
All panels are confocal images of MRLC-mTFP-expressing S. rosetta cells, unconfined (A) or confined with 2 μm (B) or 1 μm (C) microbeads. Cells were imaged as early as possible (less than a minute) …
(A–D) Flagellate S. rosetta cells are characterized by a cage of cortical microtubules that underlie the entire plasma membrane, as previously reported (Karpov and Leadbeater, 1998; Leadbeater, 2015;…
(A–D) Representative micrographs of S. rosetta cells under 2 μm confinement under the following conditions: (A) in control conditions (AKSW 0.1% DMSO), (B) after intracellular calcium depletion …
Note the dynamic intracellular distribution of myosin II foci and fibers.
(A–D) Amoeboid cell crawling after flagellar retraction (Figure 1—video 1). White arrow indicates direction of movement. (E and F) Speed and directional persistence of the cells in Figure 1—video 1 …
(A) Aspect ratio of a representative escaping cell before, during, and after escape (black line). The aspect ratio increased during escape and decreased after escape. Also depicted is the distance …
Some of the most peripheral cells (<10 μm distant of the border) manage to cross the border into the unconfined space around the pillar.
The cell elongates and polarizes in the direction of the border during crossing and resumes a round shape after having crossed.
Shown is a phylogenetic tree (modified from Brunet and King, 2017) along with information about the presence or absence (see key) of relevant cell types and cell behaviors in diverse animal …
The fraction of blebbing cells was comparable in DMSO-treated controls (left, N = 42, 60, and 9 cells in three respective biological replicates) and in cells treated with an RNA-polymerase II …
The cage surrounding the cell is called a ‘lorica’ and is a basket of silicon strips secreted and assembled by the cell. The cell is flattened but does not show blebbing or active deformation.
The strain used was SrEpac and the starting cell type was slow swimmer.
The strain used was SrEpac and the starting cell type was slow swimmer.
The strain used was SrEpac and the starting cell type was slow swimmer.
The strain used was SrEpac and the starting cell type was slow swimmer.
Blebs first form as cytoplasm-filled, F-actin-free protrusions and are re-invaded by F-actin before retraction.
Blebs first form as cytoplasm-filled, F-actin-free protrusions and are re-invaded by F-actin before retraction.
Blebs first form as cytoplasm-filled, F-actin-free protrusions and are re-invaded by F-actin before retraction.
Note the dynamic intracellular distribution of myosin II foci and fibers. Large fluorescent dots in the mTFP channel are autofluorescent food vacuoles previously described in S. rosetta (Wetzel et …
Note that expanding blebs are devoid of myosin II and are re-invaded by myosin II before retraction, similar to F-actin.
Note dynamic distribution of F-actin within the leading bleb (Figure 5G–H).
One of the blebs is then reabsorbed by the cell during escape from confinement.
The cell crawls over about 40 μm, shedding cellular material at its rear end (possibly similar to the shedding of blebs by S. rosetta; Video 11).
Left panel: DIC channel. Middle panel: result of the cell segmentation. Right panel: cell protrusions, classified into expanding blebs (orange) and retracting blebs (blue).
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Gene (Salpingoeca rosetta) | Regulatory myosin light chain short version (PTSG_00375) | NA | NCBI XM_004998867.1 | |
Strain, strain background (Salpingoeca rosetta) | S. rosetta | PMID:24139741 | ATCC PRA-390; accession number SRX365844 | |
Strain, strain background (Algoriphagus machipongonensis) | A. machipongonensis | PMID:22368173 | ATCC BAA-2233 | |
Strain, strain background (Echinicola pacifica) | E. pacifica | PMID:16627637 | DSM 19836 | |
Transfected construct (S. rosetta) | pEFl5’-Actin3’::pac-P2A-mTFP | Wetzel et al., 2018 | Addgene ID NK676 | |
Transfected construct (S. rosetta) | pEFL5'-Actin3'::pac, pActin5'-EFL3'::mCherry | This paper | Addgene ID NK802 | |
Transfected construct (S. rosetta) | pEFL5'-Actin3'::pac, pActin5'-EFL3'::LifeAct-mCherry | This paper | Addgene ID NK803 | |
Transfected construct (S. rosetta) | pEFL5'-Actin3'::pac, pActin5'-EFL3'::MRLC-mTFP | This paper | Addgene ID NK804 |
Crawling cells across animal diversity.
Pharmacological compounds used in inhibitor assays.